Cardinal Health, Inc. $CAH Shares Sold by KBC Group NV

KBC Group NV lessened its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 15.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 864,827 shares of the company’s stock after selling 157,113 shares during the quarter. KBC Group NV’s holdings in Cardinal Health were worth $182,746,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. SEB Asset Management AB purchased a new stake in Cardinal Health in the first quarter valued at approximately $16,483,000. Swiss National Bank raised its position in Cardinal Health by 7.2% during the 1st quarter. Swiss National Bank now owns 697,300 shares of the company’s stock worth $147,346,000 after buying an additional 46,900 shares during the last quarter. Hanseatic Management Services Inc. acquired a new stake in Cardinal Health during the 1st quarter valued at approximately $357,000. AIA Group Ltd lifted its stake in Cardinal Health by 12.9% during the 1st quarter. AIA Group Ltd now owns 15,947 shares of the company’s stock valued at $3,370,000 after acquiring an additional 1,823 shares during the period. Finally, Mediolanum International Funds Ltd boosted its holdings in shares of Cardinal Health by 20.0% in the 1st quarter. Mediolanum International Funds Ltd now owns 91,908 shares of the company’s stock valued at $18,962,000 after acquiring an additional 15,296 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Price Performance

Shares of NYSE CAH opened at $228.57 on Monday. The stock has a market capitalization of $53.53 billion, a price-to-earnings ratio of 34.95, a PEG ratio of 1.12 and a beta of 0.49. The firm’s 50 day simple moving average is $216.25 and its 200-day simple moving average is $213.81. Cardinal Health, Inc. has a 12 month low of $137.75 and a 12 month high of $243.21.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm had revenue of $60.94 billion during the quarter, compared to analysts’ expectations of $62.10 billion. During the same period in the previous year, the business posted $2.35 EPS. The business’s revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Analysts anticipate that Cardinal Health, Inc. will post 10.77 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st were given a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date was Wednesday, July 1st. Cardinal Health’s payout ratio is currently 31.50%.

Wall Street Analysts Forecast Growth

CAH has been the topic of a number of research reports. Weiss Ratings lowered shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research note on Tuesday, May 19th. Wells Fargo & Company decreased their target price on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Morgan Stanley upped their price target on shares of Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a report on Tuesday, April 28th. William Blair assumed coverage on Cardinal Health in a research report on Tuesday, April 28th. They set an “outperform” rating on the stock. Finally, Citigroup reiterated a “buy” rating on shares of Cardinal Health in a research note on Thursday, July 2nd. Fifteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $249.13.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.